Biocon Biologics, a subsidiary of Biocon Ltd, is a fully integrated ‘pure play’ biosimilars organization that aspires to transform patient lives through innovative and inclusive healthcare solutions.
In line with Biocon’s mission of enabling affordable access, Kiran Mazumdar Shaw, Chairperson and MD, recently reaffirmed her commitment to enable universal access to insulin to patients across the globe by offering rh-insulin therapy for less than 10 US cents/day to governments in Low and Middle Income Countries (LMICs).
It’s nearly 100 years since the development of insulin and yet even today a large number of people cannot access the therapy due to its prohibitive costs. Biocon Biologics believes this situation is untenable and is committed to change it.This year, Biocon Biologics is participating in the International Diabetes Federation (IDF) Congress, supporting its Universal Access to Insulin Program.
Biocon Biologics Symposium: 100 years of Insulin: Delivering on Universal Access & Equitable Care
Biocon Biologics has organised a satellite Symposium at IDF focussed on ‘100 years of Insulin: Delivering on Universal Access & Equitable Care’. This will have leading KOLs and thought leaders from across the globe deliberating on the critical imperative of enabling universal access to insulin. Tune in to get more insights on global access and affordability of insulins, and effective management of diabetes.
100 years of Insulin – Delivering on Universal Access & Equitable Care
Professor Andrew Boulton, President-Elect of the International Diabetes Federation (IDF) for the period 2018-19
Professor Boulton from the UK is a graduate of Newcastle-upon-Tyne and subsequently trained in Sheffield, and Miami prior to accepting an appointment at Manchester University. He has authored more than 500 peer-reviewed manuscripts and book chapters, mainly on diabetic lower limb and renal complications. Among his many awards, he has received the ADA’s Roger Pecoraro Lectureship, the EASD Camillo Golgi prize and was the first recipient of the international award on diabetic foot research. He was the 2008 winner of the ADA’s Harold Rifkin award for distinguished international service in diabetes. He received the 2012 Georgetown distinguished achievement award in diabetic limb salvage. In 2015 he visited Nagoya, Japan and gave a prize lecture on diabetic complications at the Japan Society of Diabetes, and in 2017 he was the Banting Memorial Lecturer at Diabetes UK and also received the International Diabetes Endocrinologist Award of the year from the American Association of Clinical Endocrinologists.
He is a previous editor of Diabetic Medicine and is currently an associate editor of Diabetes Care. He was the founding Chairman of the Diabetic Foot Study Group and was previously Chairman of Postgraduate Education and then Hon. Secretary/ programme chair for the EASD. Until late 2015 he was President of the EASD. Currently, President of Worldwide Initiative for Diabetes Education, Chairman of EURADIA (European Alliance for Diabetes Research) and President-Elect, International Diabetes Federation.
Prof Irl Hirsch, MD; UW professor of Metabolism, Endocrinology and Nutrition. University of Washington, USA.
Irl Hirsch, M.D., is a board certified physician at the Endocrine and Diabetes Care Center at UWMC-Roosevelt, the UW’s Diabetes Treatment and Teaching Chair and a UW professor of Metabolism, Endocrinology and Nutrition.
Dr. Hirsch’s career has focused on studying the best strategies for the use of insulin therapy and innovations in technology for diabetes management.
Dr. Hirsch earned his M.D. at the University of Missouri. He is the former chair of the Professional Practice Committee for the American Diabetes Association, and a member of the American Board of Internal Medicine. He has authored over 170 papers, numerous book chapters and six books both for patients and physicians and is section editor for UptoDate. He received the American Diabetes Association’s Josiah K. Lilly Sr. Distinguished Service Award and was elected to a Mastership by the American College of Physicians.
Dr. Radhakrishna Sothiratnam MBBS, MRCP (UK), Consultant Physician, Columbia Asia Hospital Seremban, Malaysia
Invited speaker, workshop facilitator, Debator for CPD programs & events at numerous National and International medical meetings for ministry of Health Malaysia. Principal investigator for various phase of clinical trials (Glargine, Devote etc). Recipient of National MMA branch long service Gold medal award 2007
- Principal Investigator for Basalog Post-Marketing Surveillance study (GLARG-DM-04-G-03)
- Insulin Initiation with PreMixed Insulin analogues Expert Group Consensus Meeting & Advisory Board, Tehran, Iran.
- Speaker Certification, American Diabetes Association
- Invited Speaker, Workshop Fascilitator, Debator for CPD Programs & Events at numerous National & International Medical meetings for Ministry of Health Malaysia,
- Member, Review Committee, Malaysian Clinical Practice Guidelines for the Management of Type 2 Diabetes Mellitus (5th Edition, Dec 2015)
- Member, Expert Review Committee, National Dengue CPG Guidelines for Ministry of Health Malaysia, 2007-08
- Principal Investigator, IDMPS (Insulin Glargine)
Mrs Renza Scibilia; Manager – Type 1 Diabetes and Consumer Voice, Diabetes Australia
Renza Scibilia has lived with type 1 diabetes since April 1998. She is a well-known diabetes patient advocate and activist, promoting a person-centred approach to healthcare, and in the development of diabetes information, services and technologies. Renza has worked in diabetes organisations for over 16 years and is currently the Manager of Type 1 Diabetes and Consumer Voice at Diabetes Australia. Previously, she was the Consumer Engagement Manager at a Diabetes Australia state-based organisation where she established and managed Australia’s first consumer-led and consumer-focused diabetes program, offering support, information and peer connections for people with diabetes and their families. Renza is an active and well-known member of the diabetes online community (DOC). She’s well-versed in social media and its application in diabetes peer support. Renza is the creator and author of her own diabetes blog where she writes about issues of interest to people living with diabetes. The blog, Diabetogenic (www.diabetogenic.wordpress.com), has received awards for excellence in health writing, and is one of Australia’s most widely-read consumer patient blogs. She is also a frequent contributor to health publications. Renza is a regular invited speaker at health professional, industry and patient conferences around the world, where she speaks about: why the language we use is important in healthcare; how online platforms are used to improve consumer engagement with healthcare professionals and industry; the role of people with diabetes in the design and development of health programs; and the significance of peer support.